A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Public ClinicalTrials.gov record NCT03024996. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy in Patients With Renal Cell Carcinoma at High Risk of Developing Metastasis Following Nephrectomy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase III, multicenter, randomized, placebo-controlled, double-blind study to evaluate the efficacy and safety of atezolizumab versus placebo in participants with RCC who are at high risk of disease recurrence following nephrectomy.
Study identification
- NCT ID
- NCT03024996
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 778 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2017 (Actual)
- Primary completion
- May 3, 2022 (Actual)
- Completion
- Dec 8, 2022 (Actual)
- Last update posted
- Aug 3, 2023
2017 – 2022
United States locations
- U.S. sites
- 45
- U.S. states
- 23
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic- Scottsdale | Scottsdale | Arizona | 85259 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| City of Hope, Antelope Valley | Lancaster | California | 93534 | — |
| UCLA Urology; Urology | Los Angeles | California | — | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| City of Hope-South Pasadena | South Pasadena | California | 91030 | — |
| City of Hope; Upland | Upland | California | 91786 | — |
| University of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Yale School of Medicine | New Haven | Connecticut | 06510 | — |
| Florida Cancer Specialists-Broadway, Fort Myers | Fort Myers | Florida | 33908 | — |
| University of Florida | Gainesville | Florida | 32607 | — |
| Univ of Miami, School of Med; Hem/Onc | Miami | Florida | 33136 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Emory Uni - Winship Cancer Center; Hematology/Oncology | Atlanta | Georgia | 30322 | — |
| The University of Chicago Biological Sciences; Dept. of Medicine, Section of Hematology/Oncology | Chicago | Illinois | 60637 | — |
| Loyola University Medical Center, Cardinal Bernardin Cancer Center | Maywood | Illinois | 60151 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40202 | — |
| Tulane Uni Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Chesapeake Urology Research Associates | Towson | Maryland | 21204 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Garden State Urology | Whippany | New Jersey | — | — |
| New York Oncology Hematology at Albany Medical Center | Albany | New York | 12208 | — |
| Bellevue Hospital | New York | New York | 10016 | — |
| Laura and ISAAC Perlmutter Cancer Center at NYU Langone. | New York | New York | 10016 | — |
| Mount SInai Medical Center | New York | New York | 10029 | — |
| University of Rochester Medical Center; Urology | Rochester | New York | 14642 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27514 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | — |
| Fairview Hospital; Cleveland Clinic Cancer Center | Cleveland | Ohio | 44111 | — |
| Cleveland Clinic Foundation; Hematology and Oncology | Cleveland | Ohio | 44195 | — |
| Hillcrest Hospital; Hirsch Cancer Center | Mayfield Heights | Ohio | 44124 | — |
| University of Oklahoma; Stephenson Oklahoma Canc Ctr | Oklahoma City | Oklahoma | 73104 | — |
| Oregon Health & Science Uni | Portland | Oregon | 97239 | — |
| Fox Chase Cancer Center; Hematology/Oncology | Philadelphia | Pennsylvania | 19111 | — |
| Sanford Cancer Cnt Onco Clinic | Sioux Falls | South Dakota | 57104 | — |
| Erlanger Health Systems | Chattanooga | Tennessee | 37403 | — |
| Urology Associates of Kingsport, P.C. | Kingsport | Tennessee | 37660 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Vanderbilt University Medical Center; Vanderbilt University | Nashville | Tennessee | 37232 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030-4095 | — |
| University of Utah; Huntsman Cancer Hospital | Salt Lake City | Utah | 84112 | — |
| West Virginia University Hospitals Inc | Morgantown | West Virginia | 26056 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 141 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03024996, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 3, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03024996 live on ClinicalTrials.gov.